Skip to main content

Clearstead Advisors, LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 842775 CLEVELAND, OH

Position in NBIX

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$58,146
-$247,359 QoQ
Shares Held
345
-85.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#633
of 768 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Clearstead Advisors, LLC holds $1,662,942 across 40 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (3.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 NBIX
Neurocrine Biosciences Inc
This page
345 $58,146

All Filings in NBIX

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $58,146 345
2026-03-31 $305,505 2,319
2025-12-31 $437,545 3,085
2025-09-30 $184,459 1,314
2025-06-30 $92,005 732
2025-03-31 $39,373 356
2024-12-31 $42,724 313
2024-09-30 $35,487 308
2024-06-30 $102,977 748
2024-03-31 $63,856 463
2023-12-31 $66,934 508
2023-09-30 $59,625 530
2023-06-30 $44,981 477
2023-03-31 $23,280 230